USPH (US Physical Therapy) ROCE %: 4.88% (As of Mar. 2026)


USPH US Physical Therapy Inc USPH
77 GF Score
Price $66.21
GF Value $107.60
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is US Physical Therapy ROCE %?

US Physical Therapy USPH +4.27% 77 ROCE % is 4.88% as of Mar. 2026. GuruFocus rates USPH with a GF Score™ of 77/100 and a GF Value™ of $107.60 (Significantly Undervalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. US Physical Therapy's annualized ROCE % for the quarter that ended in Mar. 2026 was 4.88%.


US Physical Therapy  (NYSE:USPH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


US Physical Therapy ROCE % Related Terms


US Physical Therapy ROCE % Historical Data

* Premium members only.

The historical data trend for US Physical Therapy's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

US Physical Therapy ROCE % Chart

US Physical Therapy Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.71 8.53 7.04 7.01 8.25

US Physical Therapy Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.44 9.48 9.44 6.45 4.88
USPH
77GF Score
US Physical Therapy Inc USPH
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

US Physical Therapy ROCE % Calculation

US Physical Therapy's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=87.272/( ( (1167.467 - 116.283) + (1204.01 - 139.04) )/ 2 )
=87.272/( (1051.184+1064.97)/ 2 )
=87.272/1058.077
=8.25 %

US Physical Therapy's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=53.416/( ( (1204.01 - 139.04) + (1242.057 - 117.298) )/ 2 )
=53.416/( ( 1064.97 + 1124.759 )/ 2 )
=53.416/1094.8645
=4.88 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 4.88% mean?
US Physical Therapy (USPH) has a ROCE % of 4.88% as of Mar. 2026.
Is US Physical Therapy's ROCE % too high?
US Physical Therapy's current ROCE % is 4.88%. The Healthcare Providers & Services industry median ROCE % is 6.41. US Physical Therapy's value of 4.88% is 23.9% below this industry median. Overall, US Physical Therapy has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does US Physical Therapy's ROCE % compare to INNV and NUTX?
US Physical Therapy's ROCE % of 4.88% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. US Physical Therapy's value of 4.88% is 23.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. US Physical Therapy's current ROCE % of 4.88% is 23.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. US Physical Therapy's current ROCE % is 4.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is US Physical Therapy stock overvalued right now?
Based on GuruFocus' analysis, US Physical Therapy (USPH) is currently considered Significantly Undervalued. The stock's GF Value™ is $107.60, compared to a current price of $66.21 — trading 38.5% below its estimated fair value. The current ROCE % is 4.88% and 23.9% below the Healthcare Providers & Services industry median of 6.41. US Physical Therapy's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For US Physical Therapy (USPH), the current ROCE % is 4.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is US Physical Therapy (USPH) Overvalued in 2026?

Based on GuruFocus' analysis, US Physical Therapy stock appears to be undervalued. The current stock price of $66.21 is trading 38.5% below its estimated GF Value™ of $107.60. GuruFocus considers US Physical Therapy to be Significantly Undervalued.

Key valuation signals for USPH:

  • ROCE %: 4.88%
  • GF Value™: $107.60 vs. price of $66.21 (38.5% below fair value)
  • GF Score™: 77/100 with 5 warning signs
  • Industry Position: 23.9% below the Healthcare Providers & Services median

No single metric tells the full story. See the USPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


US Physical Therapy Business Description

Address 1300 West Sam Houston Parkway South, Suite 300, Houston, TX, USA, 77042
US Physical Therapy Inc through its subsidiaries operate outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
77GF Score

Get the complete analysis for USPH

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$66.21
Price
$107.60
GF Value